{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T09:08:41Z","timestamp":1778749721196,"version":"3.51.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004595","name":"Universiti Sains Malaysia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004595","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"DOI":"10.1007\/s11096-025-02073-0","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T13:39:29Z","timestamp":1768311569000},"page":"789-800","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fixed dose versus 3-day loading dose warfarin initiation in atrial fibrillation: effects on INR stabilization and time in the therapeutic range"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-7592-4587","authenticated-orcid":false,"given":"Sharifah Nadiah","family":"Syed Hamzah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1025-8809","authenticated-orcid":false,"given":"Shahrul Aiman","family":"Soelar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8476-7425","authenticated-orcid":false,"given":"Sabariah Noor","family":"Harun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,13]]},"reference":[{"issue":"1","key":"2073_CR1","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1161\/CIRCEP.107.754564","volume":"1","author":"S Nattel","year":"2008","unstructured":"Nattel S, Burstein B, Dobrev D. Atrial remodeling and atrial fibrillation: mechanisms and implications. Circ Arrhythm Electrophysiol. 2008;1(1):62\u201373. https:\/\/doi.org\/10.1161\/CIRCEP.107.754564.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"1","key":"2073_CR2","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1152\/physrev.00031.2009","volume":"91","author":"U Schotten","year":"2011","unstructured":"Schotten U, Verheule S, Kirchhof P, et al. Pathophysiological mechanisms of atrial fibrillation: a translational appraisal. Physiol Rev. 2011;91(1):265\u2013325. https:\/\/doi.org\/10.1152\/physrev.00031.2009.","journal-title":"Physiol Rev"},{"issue":"5","key":"2073_CR3","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2021;42(5):373\u2013498. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa612.","journal-title":"Eur Heart J"},{"key":"2073_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006186.pub2","volume":"3","author":"MI Aguilar","year":"2007","unstructured":"Aguilar MI, Hart R, Pearce LA. Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks. Cochrane Database Syst Rev. 2007;3:CD006186. https:\/\/doi.org\/10.1002\/14651858.CD006186.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"2073_CR5","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.003482","author":"LO Dallalzadeh","year":"2016","unstructured":"Dallalzadeh LO, Go AS, Chang Y, et al. Stability of high-quality warfarin anticoagulation in a community-based atrial fibrillation cohort: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. J Am Heart Assoc. 2016. https:\/\/doi.org\/10.1161\/JAHA.116.003482.","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"2073_CR6","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1001\/archinte.167.3.239","volume":"167","author":"HD White","year":"2007","unstructured":"White HD, Gruber M, Feyzi J, et al. Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control. Arch Intern Med. 2007;167(3):239\u201345. https:\/\/doi.org\/10.1001\/archinte.167.3.239.","journal-title":"Arch Intern Med"},{"issue":"6","key":"2073_CR7","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1001\/jama.2016.9356","volume":"316","author":"SD Pokorney","year":"2016","unstructured":"Pokorney SD, Simon DN, Thomas L, et al. Stability of international normalized ratios in patients taking long-term warfarin therapy. JAMA. 2016;316(6):661\u20133. https:\/\/doi.org\/10.1001\/jama.2016.9356.","journal-title":"JAMA"},{"key":"2073_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007699.pub3","author":"P Garcia","year":"2016","unstructured":"Garcia P, Ruiz W, Loza Mun\u00e1rriz C. Warfarin initiation nomograms for venous thromboembolism. Cochrane Database Syst Rev. 2016. https:\/\/doi.org\/10.1002\/14651858.CD007699.pub3.","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"2073_CR9","doi-asserted-by":"publisher","first-page":"714","DOI":"10.7326\/0003-4819-138-9-200305060-00007","volume":"138","author":"MJ Kovacs","year":"2003","unstructured":"Kovacs MJ, Rodger M, Anderson DR, et al. Comparison of 10-mg and 5-mg warfarin initiation nomograms together with low-molecular-weight heparin for outpatient treatment of acute venous thromboembolism. Ann Intern Med. 2003;138(9):714. https:\/\/doi.org\/10.7326\/0003-4819-138-9-200305060-00007.","journal-title":"Ann Intern Med"},{"issue":"28","key":"2073_CR10","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1093\/eurheartj\/eht499","volume":"35","author":"L Azoulay","year":"2014","unstructured":"Azoulay L, Dell\u2019Aniello S, Simon TA, et al. Initiation of warfarin in patients with atrial fibrillation: early effects on ischaemic strokes. Eur Heart J. 2014;35(28):1881\u20137. https:\/\/doi.org\/10.1093\/eurheartj\/eht499.","journal-title":"Eur Heart J"},{"issue":"12","key":"2073_CR11","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1345\/aph.1E083","volume":"38","author":"CD Eckhoff","year":"2004","unstructured":"Eckhoff CD, DiDomenico RJ, Shapiro NL. Initiating warfarin therapy: 5 mg versus 10 mg. Ann Pharmacother. 2004;38(12):2115\u201321. https:\/\/doi.org\/10.1345\/aph.1E083.","journal-title":"Ann Pharmacother"},{"issue":"6","key":"2073_CR12","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s00277-010-1119-6","volume":"90","author":"GG Gan","year":"2011","unstructured":"Gan GG, Phipps ME, Lee MMT, et al. Contribution of VKORC1 and CYP2C9 polymorphisms in the interethnic variability of warfarin dose in Malaysian populations. Ann Hematol. 2011;90(6):635\u201341. https:\/\/doi.org\/10.1007\/s00277-010-1119-6.","journal-title":"Ann Hematol"},{"issue":"5","key":"2073_CR13","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1111\/cts.12771","volume":"13","author":"C Lo","year":"2020","unstructured":"Lo C, Nguyen S, Yang C, et al. Pharmacogenomics in Asian subpopulations and impacts on commonly prescribed medications. Clin Transl Sci. 2020;13(5):861. https:\/\/doi.org\/10.1111\/cts.12771.","journal-title":"Clin Transl Sci"},{"key":"2073_CR14","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.thromres.2021.12.023","volume":"210","author":"X Wang","year":"2022","unstructured":"Wang X, Tang B, Zhou M, et al. Efficacy and safety of genotype-guided warfarin dosing versus non-genotype-guided warfarin dosing strategies: a systematic review and meta-analysis of 27 randomized controlled trials. Thromb Res. 2022;210:42\u201352. https:\/\/doi.org\/10.1016\/j.thromres.2021.12.023.","journal-title":"Thromb Res"},{"issue":"3","key":"2073_CR15","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/cpt.668","volume":"102","author":"JA Johnson","year":"2017","unstructured":"Johnson JA, Caudle KE, et al. Clinical pharmacogenetics implementation consortium (CPIC) guideline for pharmacogenetics-guided warfarin dosing: 2017 update. Clin Pharmacol Ther. 2017;102(3):397\u2013404. https:\/\/doi.org\/10.1002\/cpt.668.","journal-title":"Clin Pharmacol Ther"},{"issue":"8","key":"2073_CR16","doi-asserted-by":"publisher","first-page":"599","DOI":"10.2217\/pgs-2019-0021","volume":"20","author":"G Fitzgerald","year":"2019","unstructured":"Fitzgerald G, Prince C, Downing J, et al. Processes and barriers to implementation of point-of-care genotype-guided dosing of warfarin into UK outpatient anticoagulation clinics. Pharmacogenomics. 2019;20(8):599\u2013608. https:\/\/doi.org\/10.2217\/pgs-2019-0021.","journal-title":"Pharmacogenomics"},{"issue":"2","key":"2073_CR17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12170-022-00713-y","volume":"17","author":"S Tuteja","year":"2023","unstructured":"Tuteja S. Application of pharmacogenetics for the use of antiplatelet and anticoagulant drugs. Curr Cardiovasc Risk Rep. 2023;17(2):27\u201338. https:\/\/doi.org\/10.1007\/s12170-022-00713-y.","journal-title":"Curr Cardiovasc Risk Rep"},{"key":"2073_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2022.866058","volume":"13","author":"IG Asiimwe","year":"2022","unstructured":"Asiimwe IG, Pirmohamed M. Ethnic diversity and warfarin pharmacogenomics. Front Pharmacol. 2022;13:1\u201321. https:\/\/doi.org\/10.3389\/fphar.2022.866058.","journal-title":"Front Pharmacol"},{"issue":"3","key":"2073_CR19","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s11096-022-01386-8","volume":"44","author":"AM Fahmi","year":"2022","unstructured":"Fahmi AM, Elewa H, El Jilany I. Warfarin dosing strategies evolution and its progress in the era of precision medicine, a narrative review. Int J Clin Pharm. 2022;44(3):599\u2013607. https:\/\/doi.org\/10.1007\/s11096-022-01386-8.","journal-title":"Int J Clin Pharm"},{"key":"2073_CR20","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.thromres.2019.11.012","volume":"185","author":"SS Ng","year":"2020","unstructured":"Ng SS, Nathisuwan S, Phrommintikul A, et al. Cost-effectiveness of warfarin care bundles and novel oral anticoagulants for stroke prevention in patients with atrial fibrillation in Thailand. Thromb Res. 2020;185:63\u201371. https:\/\/doi.org\/10.1016\/j.thromres.2019.11.012.","journal-title":"Thromb Res"},{"issue":"9","key":"2073_CR21","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.3390\/jcm13092675","volume":"13","author":"S Ujjin","year":"2024","unstructured":"Ujjin S, Chancharoenthana W, Jantarasaengaram S, et al. Comparison of clinical algorithm-based and genotype-guided warfarin dosing in Thai patients: a randomized controlled study. J Clin Med. 2024;13(9):2675. https:\/\/doi.org\/10.3390\/jcm13092675.","journal-title":"J Clin Med"},{"key":"2073_CR22","unstructured":"Pharmaceutical Services Program. Anticoagulation MTAC (AC-MTAC) protocol. Petaling Jaya. Ministry of Health Malaysia; 2020. ISBN: 978\u2013967\u20135570\u201385\u20138. Available from: www.pharmacy.gov.my. Accessed 25 Aug 2020."},{"issue":"9","key":"2073_CR23","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1253\/circj.CJ-11-0350","volume":"75","author":"K Okumura","year":"2011","unstructured":"Okumura K, Komatsu T, Yamashita T, et al. Time in the Therapeutic Range During Warfarin Therapy in Japanese Patients With Non-Valvular Atrial Fibrillation - A Multicenter Study of Its Status and Influential Factors -: \u2013 A Multicenter Study of Its Status and Influential Factors \u2013. Circ J. 2011;75(9):2087\u201394. https:\/\/doi.org\/10.1253\/circj.CJ-11-0350.","journal-title":"Circ J"},{"issue":"6","key":"2073_CR24","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/phar.2089","volume":"38","author":"A Shendre","year":"2018","unstructured":"Shendre A, Parmar GM, Dillon C, et al. Influence of age on warfarin dose, anticoagulation control, and risk of hemorrhage. Pharmacotherapy. 2018;38(6):588\u201396. https:\/\/doi.org\/10.1002\/phar.2089.","journal-title":"Pharmacotherapy"},{"key":"2073_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.archger.2022.104661","volume":"101","author":"M Akishita","year":"2022","unstructured":"Akishita M, Suzuki S, Inoue H, et al. Frailty and outcomes in older adults with non-valvular atrial fibrillation from the ANAFIE registry. Arch Gerontol Geriatr. 2022;101:104661. https:\/\/doi.org\/10.1016\/j.archger.2022.104661.","journal-title":"Arch Gerontol Geriatr"},{"issue":"4","key":"2073_CR26","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/s11096-022-01404-9","volume":"44","author":"W Yang","year":"2022","unstructured":"Yang W, Ma J, Hu W, et al. Associated factors and safety of the rapidly achieving first therapeutic target of warfarin in hospitalized patients: a retrospective cohort study. Int J Clin Pharm. 2022;44(4):939\u201346. https:\/\/doi.org\/10.1007\/s11096-022-01404-9.","journal-title":"Int J Clin Pharm"},{"key":"2073_CR27","doi-asserted-by":"publisher","unstructured":"Mohamed S, Chan MF, Yew JM, et al. Evaluation of an initiation regimen of warfarin for international normalized ratio target 2.0 to 3.0. J Pharm Technol. 2021;37(6):286\u201392. https:\/\/doi.org\/10.1177\/87551225211034175","DOI":"10.1177\/87551225211034175"},{"issue":"3","key":"2073_CR28","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1055\/s-0038-1651587","volume":"69","author":"FR Rosendaal","year":"1993","unstructured":"Rosendaal FR, Cannegieter SC, Van der Meer FJM, et al. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost. 1993;69(3):236\u20139. https:\/\/doi.org\/10.1055\/s-0038-1651587.","journal-title":"Thromb Haemost"},{"key":"2073_CR29","doi-asserted-by":"publisher","unstructured":"Aidit S, Soh YC, Yap CS, et al. Effect of standardized warfarin treatment protocol on anticoagulant effect: comparison of a warfarin medication therapy adherence clinic with usual medical care. Front Pharmacol. 2017;8(Nov):1\u201310. https:\/\/doi.org\/10.3389\/fphar.2017.00637","DOI":"10.3389\/fphar.2017.00637"},{"issue":"5","key":"2073_CR30","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1007\/s11096-018-0674-0","volume":"40","author":"H Cao","year":"2018","unstructured":"Cao H, Wu J, Zhang J. Outcomes of warfarin therapy managed by pharmacists via hospital anticoagulation clinic versus online anticoagulation clinic. Int J Clin Pharm. 2018;40(5):1072\u20137. https:\/\/doi.org\/10.1007\/s11096-018-0674-0.","journal-title":"Int J Clin Pharm"},{"issue":"6","key":"2073_CR31","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1002\/cpt.3207","volume":"115","author":"L Xue","year":"2024","unstructured":"Xue L, Ma G, Holford N, et al. A randomized trial comparing standard of care to Bayesian warfarin dose individualization. Clin Pharmacol Ther. 2024;115(6):1316\u201325. https:\/\/doi.org\/10.1002\/cpt.3207.","journal-title":"Clin Pharmacol Ther"},{"key":"2073_CR32","volume-title":"Principles of statistics","author":"MG Bulmer","year":"1979","unstructured":"Bulmer MG. Principles of statistics. New York: Dover Publications; 1979."},{"issue":"2","key":"2073_CR33","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1080\/00031305.1988.10475539","volume":"42","author":"KP Balanda","year":"1988","unstructured":"Balanda KP, MacGillivray HL. Kurtosis: A Critical Review. Am Stat. 1988;42(2):111\u20139. https:\/\/doi.org\/10.1080\/00031305.1988.10475539.","journal-title":"Am Stat"},{"key":"2073_CR34","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.2147\/JPR.S305399","volume":"14","author":"HJ Dong","year":"2021","unstructured":"Dong HJ, Dragioti E, Rivano Fischer M, Gerdle B. Lose pain, lose weight, and lose both: a cohort study of patients with chronic pain and obesity using a national quality registry. J Pain Res. 2021;14:1863\u201373. https:\/\/doi.org\/10.2147\/JPR.S305399.","journal-title":"J Pain Res"},{"issue":"12","key":"2073_CR35","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1093\/eurheartj\/ehw565","volume":"38","author":"CL Fanola","year":"2017","unstructured":"Fanola CL, Giugliano RP, Ruff CT, et al. A novel risk prediction score in atrial fibrillation for a net clinical outcome from the ENGAGE AF-TIMI 48 randomized clinical trial. Eur Heart J. 2017;38(12):888\u201396. https:\/\/doi.org\/10.1093\/eurheartj\/ehw565.","journal-title":"Eur Heart J"},{"issue":"6","key":"2073_CR36","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1007\/s11096-017-0511-x","volume":"39","author":"RG de Lima Silva","year":"2017","unstructured":"de Lima Silva RG, Bertollo CM, Ferreira IG, et al. Assessment of oral anticoagulation control at two pharmacist-managed clinics in Brazil. Int J Clin Pharm. 2017;39(6):1157\u201361. https:\/\/doi.org\/10.1007\/s11096-017-0511-x.","journal-title":"Int J Clin Pharm"},{"issue":"1","key":"2073_CR37","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s11096-022-01471-y","volume":"45","author":"K Sridharan","year":"2023","unstructured":"Sridharan K, Ramanathan M, Al Banna R. Evaluation of supervised machine learning algorithms in predicting the poor anticoagulation control and stable weekly doses of warfarin. Int J Clin Pharm. 2023;45(1):79\u201387. https:\/\/doi.org\/10.1007\/s11096-022-01471-y.","journal-title":"Int J Clin Pharm"},{"issue":"6","key":"2073_CR38","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/tpj.2015.16","volume":"15","author":"HL Tang","year":"2015","unstructured":"Tang HL, Shi WL, Li XG, et al. Limited clinical utility of genotype-guided warfarin initiation dosing algorithms versus standard therapy: a meta-analysis and trial sequential analysis of 11 randomized controlled trials. Pharmacogenomics J. 2015;15(6):496\u2013504. https:\/\/doi.org\/10.1038\/tpj.2015.16.","journal-title":"Pharmacogenomics J"},{"issue":"24","key":"2073_CR39","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1056\/NEJMoa1311386","volume":"369","author":"M Pirmohamed","year":"2013","unstructured":"Pirmohamed M, Burnside G, Eriksson N, et al. A randomized trial of genotype-guided dosing of warfarin. N Engl J Med. 2013;369(24):2294\u2013303. https:\/\/doi.org\/10.1056\/NEJMoa1311386.","journal-title":"N Engl J Med"},{"issue":"24","key":"2073_CR40","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1056\/NEJMoa1310669","volume":"369","author":"SE Kimmel","year":"2013","unstructured":"Kimmel SE, French B, Kasner SE, et al. A pharmacogenetic versus a clinical algorithm for warfarin dosing. N Engl J Med. 2013;369(24):2283\u201393. https:\/\/doi.org\/10.1056\/NEJMoa1310669.","journal-title":"N Engl J Med"},{"issue":"3","key":"2073_CR41","doi-asserted-by":"publisher","first-page":"458","DOI":"10.3904\/kjim.2023.381","volume":"39","author":"SW Jeon","year":"2024","unstructured":"Jeon SW, Lee N, Lee KH, et al. Modified application of SAMe-TT2R2 scoring system in Asian patients with atrial fibrillation for the selection of oral anticoagulants. Korean J Intern Med. 2024;39(3):458\u201368. https:\/\/doi.org\/10.3904\/kjim.2023.381.","journal-title":"Korean J Intern Med"},{"issue":"2","key":"2073_CR42","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s40256-023-00623-3","volume":"24","author":"N Poonchuay","year":"2024","unstructured":"Poonchuay N, Saokaew S, Incomenoy S. SAMe-TT2R2 score to predict time in therapeutic range of vitamin K antagonists in Asian and non-Asian patients: a systematic review and meta-analysis. Am J Cardiovasc Drugs. 2024;24(2):211\u201340. https:\/\/doi.org\/10.1007\/s40256-023-00623-3.","journal-title":"Am J Cardiovasc Drugs"},{"issue":"1","key":"2073_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-023-45379-7","volume":"13","author":"W Luo","year":"2023","unstructured":"Luo W, Luo X, Chen S, et al. Chinese stroke patients with atrial fibrillation used Robert\u2019s age-adjusted warfarin loading protocol obtained good INR results within therapeutic range. Sci Rep. 2023;13(1):1\u20139. https:\/\/doi.org\/10.1038\/s41598-023-45379-7.","journal-title":"Sci Rep"},{"issue":"3","key":"2073_CR44","doi-asserted-by":"publisher","first-page":"292","DOI":"10.46542\/pe.2024.243.292297","volume":"24","author":"EMS Kundiman","year":"2024","unstructured":"Kundiman EMS, Ramadhanty ZT, Suprapti B, et al. Evaluation of the four mg warfarin initiation dose in patients with cardiovascular disease. Pharm Educ. 2024;24(3):292\u20137. https:\/\/doi.org\/10.46542\/pe.2024.243.292297.","journal-title":"Pharm Educ"},{"issue":"4","key":"2073_CR45","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/jppr.1965","volume":"55","author":"W Mazlan\u2010Kepli","year":"2025","unstructured":"Mazlan\u2010Kepli W, Mohamed S, Nik\u2010Ismail N, et al. Anticoagulation control of warfarin in anticoagulation medication therapy adherence clinics. J Pharm Pract Res. 2025;55(4):327\u201335. https:\/\/doi.org\/10.1002\/jppr.1965.","journal-title":"J Pharm Pract Res"},{"issue":"4","key":"2073_CR46","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s40261-022-01137-7","volume":"42","author":"S Sabry","year":"2022","unstructured":"Sabry S, El Wakeel LM, Saleh A, et al. Comparison of warfarin initiation at 3 mg versus 5 mg for anticoagulation of patients with mechanical mitral valve replacement surgery: a prospective randomized trial. Clin Drug Investig. 2022;42(4):309\u201318. https:\/\/doi.org\/10.1007\/s40261-022-01137-7.","journal-title":"Clin Drug Investig"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-025-02073-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-025-02073-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-025-02073-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:16:09Z","timestamp":1778746569000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-025-02073-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,13]]},"references-count":46,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["2073"],"URL":"https:\/\/doi.org\/10.1007\/s11096-025-02073-0","relation":{},"ISSN":["2210-7711"],"issn-type":[{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,13]]},"assertion":[{"value":"8 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki. Ethics approval was obtained from the Medical Research and Ethics Committee (MREC), Ministry of Health Malaysia (NMRR ID-23\u201302805- II8 (IIR)] on 24th October 2023, and the Human Research Ethics Committee USM (HREC) (USM\/JEPeM\/PP\/23100806), Universiti Sains Malaysia, on 22nd March 2024. Simultaneously, a waiver of informed consent was obtained due to the nature of the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}